Stock Futures Modestly Higher, Okloup Shares Surge 18%
Stock futures are modestly higher after the December nonfarm payrolls report and ahead of a looming Supreme Court decision on President Trump's tariff policy. Major indexes have shown resilience early in 2026 after a strong finish to 2025, but the run of gains has met headwinds this week as investors weigh cooling tech momentum and the uncertainty around incoming labor data that could influence expectations for the Federal Reserve's policy path.Defensive sectors such as energy and mining have shown relative strength, while value-oriented and cyclical areas are attracting attention amid the rotation, and safe-haven assets like gold have also drawn demand as risk sentiment fluctuates.In pre-market trading, S&P 500 futures rose 0.33%, Nasdaq futures rose 0.42% and Dow futures rose 0.32%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Okloup 18% after announcing an agreement with Meta Platformsthat advances Oklo's plans to develop a 1.2 GW power campus in Pike County, Ohio, to support Meta's data centers in the regionVistraup 17% after entering into 20-year purchase power agreements to provide more than 2,600 megawatts of zero-carbon energy from a combination of three different Vistra nuclear plants to support Meta's operations in the regionIntelup 2% after President Trump reported a "great meeting" with CEO Lip-Bu TanUP AFTER TRUMP RECOMMENDED THE PURCHASE OF $200B IN MORTGAGE BONDS -Offerpad Solutionsup 48%LoanDepotup 16%Opendoor Technologiesup 11%Rocket Companiesup 6%UWM Holdingsup 6%DOWN AFTER EARNINGS -WD-40down 8%LOWER -Aquestive Therapeuticsdown 37% after the FDA notified the company that it had identified deficiencies in the Anaphylm NDA that preclude discussion of labeling and post-marketing commitments at this timeAXT Inc.down 14% after axing its Q4 revenue outlook
Trade with 70% Backtested Accuracy
Analyst Views on OKLO
About OKLO
About the author

- Regulatory Approval Progress: On March 17, Oklo received approval from the U.S. Department of Energy (DoE) for its subsidiary Atomic Alchemy's Groves Isotopes Test Reactor in Texas, marking significant progress in its nuclear initiatives, yet the stock plummeted by 20% following the announcement.
- Materials License Granted: Oklo secured its first-ever materials license from the U.S. Nuclear Regulatory Commission (NRC), allowing Atomic Alchemy to receive, store, and use isotopes like Radium-266 and Cobalt-60, which lays a foundation for future commercial operations despite failing to boost stock prices significantly.
- Aurora Powerhouse Project Approval: The Idaho Aurora Powerhouse project received NSDA approval from the DoE, locking in the safety and regulatory framework, with the next step being a Preliminary Documented Safety Analysis, although market sentiment remains cautious regarding its commercialization prospects.
- Importance of NRC Approval: Despite multiple DoE approvals, Oklo's business model hinges on obtaining NRC approval for commercial operation, which means that while current approvals are crucial, they have not significantly restored investor confidence, with shares trading below $50.
- Regulatory Progress: On March 17, Oklo received a Nuclear Safety Design Agreement from the U.S. Department of Energy for its Groves Isotopes Test Reactor in Texas, which is expected to create a reliable domestic supply of nuclear isotopes for various industries, thereby enhancing the company's market competitiveness.
- First NRC License: Oklo secured its first materials license from the U.S. Nuclear Regulatory Commission, allowing it to use and store isotopes such as Radium-266, Cobalt-60, and Americium-241, laying a foundation for business expansion despite the market's tepid response.
- Flagship Project Approval: The Idaho Aurora Powerhouse project received NSDA approval from the DOE, locking in the safety and regulatory framework, with the next step being a Preliminary Documented Safety Analysis that will facilitate final design and construction, indicating progress toward operational readiness.
- Market Reaction Analysis: Despite these significant regulatory approvals, Oklo's stock has dropped 20%, primarily due to market focus on the need for commercial operation approval for the Aurora Powerhouse, reflecting investor caution regarding the company's future prospects.
- Stock Performance: Oklo Inc. (NYSE:OKLO) has seen its shares rise by 119% over the past year, yet it has declined by 38% year-to-date, indicating market concerns about its future development.
- Analyst Ratings: William Blair maintained an Outperform rating for Oklo on March 18, while Needham lowered its price target from $135 to $73, yet kept a Buy rating, reflecting a divergence in market outlook.
- Deployment Plans: Oklo projects a deployment of 3 gigawatts of nuclear energy by 2035; however, Cramer noted that the company is still in a “science project” phase, suggesting challenges in its commercialization process.
- Market Competition: Cramer advised investors to focus on GE Vernova, believing it has a more realistic timeline for nuclear equipment provision, emphasizing the higher investment risks associated with Oklo, which may lack short-term profitability.
CERAWeek Conference: The CERAWeek conference in Houston, Texas, brings together major players in energy and technology to discuss global energy markets, geopolitics, and the increasing demand for electricity, highlighting the U.S.'s dependence on electricity and the challenges posed by AI-driven infrastructure needs.
Electricity Demand Trends: U.S. electricity demand is outpacing grid capacity, with significant increases in power consumption driven by industrialization, data centers, and AI computing, creating investment opportunities and potential pitfalls in infrastructure development.
Market Dynamics: Companies like MasTec, Regal Rexnord, and EQT are positioned to capitalize on the growing demand for energy and AI infrastructure, despite facing challenges such as high capital expenditures and fluctuating market conditions.
Investment Insights: Analysts suggest that while some companies are experiencing negative profit margins, others with strong backlogs and proven demand are well-positioned for growth, emphasizing the importance of understanding market dynamics and investment opportunities in the evolving energy landscape.
- Nuclear Renaissance Outlook: According to Bank of America, nuclear energy has been rediscovered amid surging electricity demand, with the total potential value of the nuclear renaissance estimated at $10 trillion, indicating significant investment opportunities.
- NuScale Power Status: NuScale Power's market cap has fallen to $3.7 billion, with shares down about one-third since the beginning of the year; despite its small modular reactor (SMR) technology not yet being deployed at scale, investing at current prices remains attractive.
- Oklo's Market Advantage: With a market capitalization of $9 billion, Oklo is valued significantly higher than NuScale, but its extensive deal pipeline with major tech companies and data centers provides a clear competitive edge, with its first reactor expected to be operational by 2027.
- Investment Risks and Opportunities: While Oklo has a buy rating from Bank of America with a price target of $127, it was not included in Motley Fool's list of top investment stocks, prompting investors to carefully assess potential execution risks against market opportunities.
- Nuclear Renaissance Outlook: Analysts from Bank of America highlight a nuclear renaissance driven by surging electricity demand, estimating the total potential value of this sector could reach $10 trillion, indicating significant investment opportunities in nuclear energy.
- NuScale Power Status: NuScale Power's market cap has fallen to $3.7 billion, with shares down approximately one-third since the beginning of the year; despite its small modular reactor (SMR) technology not yet being widely adopted, there remains potential for substantial future growth.
- Oklo's Market Advantage: With a market cap of $9 billion, Oklo is valued significantly higher than NuScale and has established extensive partnerships with major tech companies, with its first reactor expected to be deployed by 2027, showcasing strong execution capabilities in the nuclear sector.
- Investment Risks and Opportunities: While NuScale faces delays in customer agreements, Oklo's buy rating and $127 price target suggest investor optimism about the nuclear industry's future, particularly as AI drives increased electricity demand.











